In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of the coronavirus disease 2019 (COVID-19) pandemic on the rates of pancreatic enzyme replacement therapy ...
VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the root cause of the insufficiency, according to results ...
LOS ANGELES, Sept. 22, 2021 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN) announced today that it will provide the pancreatic enzyme drug, CREON®, for supportive care use to patients ...
Just two years after its founding, Alnara Pharmaceuticals Inc. agreed to be acquired by Eli Lilly and Co. Terms of the all-cash deal were not disclosed, but they should be fairly significant given ...
Please provide your email address to receive an email when new articles are posted on . Exocrine pancreatic insufficiency should be suspected among patients with high-risk clinical conditions, such as ...
If you’ve received an exocrine pancreatic insufficiency (EPI) diagnosis, you might come across some new medical terms when talking with your doctor. Here are the most common ones to familiarize ...
This graph illustrates the mean EPI-Q scores over time for patients undergoing pancreatoduodenectomy (PD) and distal pancreatectomy (DP). The scores, representing the severity of EPI symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results